F344/NHsd |
mean corpuscular volume |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
erythrocyte size trait |
female |
56 days-98 days |
8 |
|
|
52.0 |
fl |
0.25 |
0.7 |
automated blood analysis |
|
0.0 |
0 |
|
Anilytics |
|
13170 |
332 |
SHR/NHsd |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
3.6 |
mg/dl |
0.15 |
0.42 |
automated blood analysis |
|
0 |
0 |
|
|
|
65787 |
246 |
SHR/Mol |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood glucose amount |
not specified |
84 days-98 days |
24 |
|
|
102.0 |
mg/dl |
1.02 |
5.0 |
automated blood analysis |
opthalmic plexus |
0.0 |
0 |
|
mean of samples at 12, 13 and 14 weeks |
|
12932 |
323 |
SHR/Mol |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood triglyceride amount |
male |
84 days-98 days |
12 |
|
|
97.35 |
mg/dl |
2.55 |
8.85 |
automated blood analysis |
opthalmic plexus |
|
0 |
|
mean of samples at 12, 13 and 14 weeks |
|
12934 |
323 |
GK/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood glucose amount |
female |
60 days
| 6 |
|
|
262.8 |
mg/dl |
16.02 |
39.24 |
automated blood analysis |
|
0.0 |
0 |
|
automated plasma glucose analysis |
mM |
68775 |
1012 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma creatinine level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175 days
| 20 |
|
|
0.61 |
mg/dl |
0.03 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67761 |
110 |
WKY/NCruk |
plasma creatinine level |
left nephrectomy and left kidney transplant then right nephrectomy |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175 days
| 17 |
|
|
0.52 |
mg/dl |
0.03 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67764 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma urea nitrogen level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood urea nitrogen amount |
male |
35 days
| 19 |
|
|
4.38 |
mmol/l |
0.17 |
0.73 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67769 |
110 |
F344/NHsd |
blood lymphocyte count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
lymphocyte quantity |
female |
56 days-98 days |
8 |
|
|
6.75 |
x 1000 cells/ul |
0.92 |
2.6 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68382 |
332 |
BN/Crl |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
male |
90 days
| 22 |
|
|
0.79 |
mmol/l |
0.03 |
0.14 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68421 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
female |
90 days
| 6 |
|
|
0.81 |
mmol/l |
0.06 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68429 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
male |
90 days
| 10 |
|
|
1.16 |
mmol/l |
0.04 |
0.13 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68434 |
69 |
BN/Crl |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
male |
90 days
| 26 |
|
|
27.03 |
mg/dl |
0.77 |
3.94 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68441 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
male |
90 days
| 10 |
|
|
32.43 |
mg/dl |
0.39 |
1.22 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68445 |
69 |
BN/Crl |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
female |
90 days
| 22 |
|
|
32.43 |
mg/dl |
0.77 |
3.62 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68446 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
female |
90 days
| 6 |
|
|
33.98 |
mg/dl |
1.16 |
2.84 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68449 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
female |
90 days
| 6 |
|
|
32.43 |
mg/dl |
0.77 |
1.89 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68450 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
female |
90 days
| 6 |
|
|
7.72 |
mg/dl |
0.77 |
1.89 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68460 |
69 |
SD |
blood sodium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
male |
71 days-85 days |
6 |
|
|
147.8 |
mmol/l |
0.7 |
1.72 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85122 |
1602 |
SD |
blood sodium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
male |
85 days-99 days |
6 |
|
|
104.23 |
mmol/l |
24.73 |
60.57 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85124 |
1602 |
SD |
blood sodium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
female |
71 days-85 days |
6 |
|
|
150.33 |
mmol/l |
0.76 |
1.86 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85128 |
1602 |
SD |
blood sodium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
female |
85 days-99 days |
6 |
|
|
145.33 |
mmol/l |
0.92 |
2.25 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85130 |
1602 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
70 days
| 19 |
|
|
14.7 |
mg/dl |
1.1 |
4.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85355 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
119 days
| 19 |
|
|
19.8 |
mg/dl |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85362 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
105 days
| 19 |
|
|
0.41 |
mg/dl |
0.01 |
0.03 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85373 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
78 days
| 19 |
|
|
61.0 |
U/l |
2.09 |
9.1 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85412 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
105 days
| 19 |
|
|
58.4 |
U/l |
1.06 |
4.6 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85417 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
133 days
| 19 |
|
|
57.1 |
U/l |
2.18 |
9.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85420 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
91 days
| 19 |
|
|
35.4 |
U/l |
1.49 |
6.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85431 |
1604 |
FHH/EurMcwi |
blood urea nitrogen level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood urea nitrogen amount |
male |
189 days
| 7 |
|
|
20.5 |
mg/dl |
3.22 |
8.52 |
automated blood analysis |
|
0.0 |
0 |
|
ACE Autoanalyzer Clinical Chemistry System |
|
96905 |
1738 |
FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
blood urea nitrogen level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood urea nitrogen amount |
male |
189 days
| 9 |
|
|
25.89 |
mg/dl |
3.59 |
10.77 |
automated blood analysis |
|
0.0 |
0 |
|
ACE Autoanalyzer Clinical Chemistry System |
|
96907 |
1738 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
91 days
| 19 |
|
|
14.4 |
U/l |
1.19 |
5.2 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85446 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
147 days
| 19 |
|
|
13.4 |
U/l |
0.41 |
1.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85455 |
1604 |
SD |
blood urea nitrogen level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
female |
71 days-85 days |
6 |
|
|
18.7 |
mg/dl |
0.56 |
1.37 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85041 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71 days-85 days |
6 |
|
|
0.9 |
null |
0.02 |
0.04 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85050 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
71 days-85 days |
6 |
|
|
1.1 |
null |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85054 |
1602 |
SD |
blood creatinine level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
male |
71 days-85 days |
6 |
|
|
0.4 |
mg/dl |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85061 |
1602 |
SD |
blood creatinine level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
female |
71 days-85 days |
6 |
|
|
0.4 |
mg/dl |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85066 |
1602 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
male |
71 days-85 days |
6 |
|
|
136.8 |
U/l |
11.03 |
27.01 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85072 |
1602 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
female |
71 days-85 days |
6 |
|
|
116.83 |
U/l |
7.25 |
17.76 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85079 |
1602 |
SD |
blood alanine aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
male |
71 days-85 days |
6 |
|
|
46.7 |
U/l |
2.05 |
5.01 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85083 |
1602 |
SD |
blood alanine aminotransferase activity level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
male |
71 days-85 days |
6 |
|
|
59.8 |
U/l |
2.44 |
5.98 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85085 |
1602 |
SD |
blood alanine aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
female |
71 days-85 days |
6 |
|
|
116.5 |
U/l |
13.45 |
32.94 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85094 |
1602 |
SD |
blood alkaline phosphatase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
male |
85 days-99 days |
6 |
|
|
268.14 |
U/l |
48.98 |
119.97 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85099 |
1602 |
SD |
blood bilirubin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
male |
85 days-99 days |
6 |
|
|
0.52 |
mg/dl |
0.09 |
0.22 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85111 |
1602 |
SD |
blood potassium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
female |
85 days-99 days |
6 |
|
|
4.7 |
mmol/l |
0.11 |
0.28 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85141 |
1602 |
SD |
blood triglyceride level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
male |
71 days-85 days |
6 |
|
|
141.2 |
mg/dl |
39.8 |
97.48 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85180 |
1602 |
SD |
blood calcium level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
male |
71 days-85 days |
6 |
|
|
10.2 |
mg/dl |
0.1 |
0.24 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85145 |
1602 |
SD |
blood calcium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
female |
71 days-85 days |
6 |
|
|
9.95 |
mg/dl |
0.08 |
0.19 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85149 |
1602 |
SD |
blood calcium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
female |
85 days-99 days |
6 |
|
|
10.23 |
mg/dl |
0.13 |
0.32 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85153 |
1602 |
Hsd:WI |
plasma alanine aminotransferase activity level |
fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood alanine transaminase amount |
not specified |
0 days
| 10 |
|
|
43.3 |
U/l |
3.38 |
10.7 |
automated blood analysis |
|
0.0 |
0 |
|
Architect c16000; Abbott Laboratories, USA |
|
85590 |
1618 |
SD |
blood creatinine level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
female |
71 days-85 days |
6 |
|
|
0.3 |
mg/dl |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85067 |
1602 |
SD |
blood alkaline phosphatase activity level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
male |
71 days-85 days |
6 |
|
|
469.0 |
U/l |
85.91 |
210.44 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85096 |
1602 |
Hsd:WI |
plasma alanine aminotransferase activity level |
acetaminophen (500 mg/kg) (for 1 days) then thymoquinone (15 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood alanine transaminase amount |
not specified |
0 days
| 10 |
|
|
52.9 |
U/l |
3.26 |
10.3 |
automated blood analysis |
|
0.0 |
0 |
|
Architect c16000; Abbott Laboratories, USA |
|
85593 |
1618 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
78 days
| 19 |
|
|
126.0 |
mg/dl |
2.06 |
9.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85325 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
105 days
| 19 |
|
|
121.0 |
mg/dl |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85329 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
147 days
| 19 |
|
|
34.4 |
U/l |
1.31 |
5.7 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85439 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
168 days
| 19 |
|
|
37.3 |
U/l |
0.96 |
4.2 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85440 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
133 days
| 19 |
|
|
17.0 |
U/l |
0.71 |
3.1 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85452 |
1604 |
SD |
blood glucose level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
71 days-85 days |
6 |
|
|
109.2 |
mg/dl |
11.08 |
27.13 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84994 |
1602 |
SD |
blood total cholesterol level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
male |
71 days-85 days |
6 |
|
|
87.8 |
mg/dl |
3.31 |
8.11 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85169 |
1602 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
147 days
| 19 |
|
|
54.3 |
U/l |
1.26 |
5.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85423 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
168 days
| 19 |
|
|
52.7 |
U/l |
1.26 |
5.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85424 |
1604 |
SD |
blood albumin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
85 days-99 days |
6 |
|
|
2.48 |
g/dl |
0.57 |
1.39 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85004 |
1602 |
SS.ZUC-Leprfa+/+/Slc |
serum alanine aminotransferase activity level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood alanine transaminase amount |
male |
126 days
| 6 |
|
|
24.67 |
U/l |
0.88 |
2.16 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101929 |
2642 |
SS.ZUC-Leprfa+/+/Slc |
blood alanine aminotransferase activity level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood alanine transaminase amount |
male |
91 days
| 8 |
|
|
20.5 |
U/l |
0.5 |
1.41 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101861 |
2641 |
SD-Fhem1+/+ |
blood hemoglobin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
male |
0 days
| 3 |
|
|
1460.0 |
g/dl |
28.87 |
50.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104853 |
2989 |
SD-Fhem1+/- |
platelet count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet quantity |
female |
0 days
| 3 |
|
|
964.3 |
x 1000 /ul |
62.24 |
107.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104864 |
2989 |
SD-Fhem1+/+ |
blood monocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
male |
0 days
| 3 |
|
|
0.3 |
x 1000 cells/ul |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104901 |
2989 |
SD-Fhem1+/+ |
blood eosinophil count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
female |
0 days
| 3 |
|
|
0.1 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104906 |
2989 |
SD-Fhem1+/- |
mean corpuscular hemoglobin concentration |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
0 days
| 3 |
|
|
3433.0 |
g/dl |
12.7 |
22.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104884 |
2989 |
SD-Fhem1+/+ |
blood monocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
monocyte quantity |
male |
0 days
| 3 |
|
|
4.6 |
% |
0.06 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104889 |
2989 |
SD-Fhem1+/+ |
platelet distribution width |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
0 days
| 3 |
|
|
9.5 |
fl |
0.29 |
0.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104918 |
2989 |
SD-Fhem1+/- |
platelet distribution width |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
male |
0 days
| 3 |
|
|
8.9 |
fl |
0.58 |
1.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104919 |
2989 |
SD-Fhem1+/- |
platelet-large cell ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
0 days
| 3 |
|
|
16.1 |
% |
1.62 |
2.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104924 |
2989 |
SD-Fhem1+/+ |
blood aspartate aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood aspartate transaminase amount |
female |
0 days
| 3 |
|
|
114.7 |
U/l |
8.31 |
14.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104930 |
2989 |
SD-Fhem1+/- |
plasma direct bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
male |
0 days
| 3 |
|
|
0.3 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104947 |
2989 |
Crl:LE |
blood hemoglobin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood hemoglobin amount |
male |
91 days
| 5 |
|
|
16.4 |
g/dl |
0.36 |
0.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104357 |
2947 |
LE-Lrrk2em1Sage-/- |
blood hemoglobin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood hemoglobin amount |
male |
91 days
| 5 |
|
|
15.1 |
g/dl |
0.27 |
0.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104358 |
2947 |
Crl:LE |
blood monocyte count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
monocyte quantity |
male |
91 days
| 5 |
|
|
0.14 |
x 1000 cells/ul |
0.04 |
0.09 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104381 |
2947 |
LE-Lrrk2em1Sage-/- |
blood eosinophil count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
eosinophil quantity |
male |
91 days
| 5 |
|
|
0.08 |
x 1000 cells/ul |
0.0 |
0.01 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104384 |
2947 |
SS-Kcnj1em1Kasu+/- |
blood potassium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood potassium amount |
male |
13 days
| 6 |
|
|
4.7 |
mmol/l |
0.2 |
0.49 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104428 |
2948 |
SS-Kcnj1em1Kasu-/- |
blood pH |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood acidity-alkalinity balance trait |
male |
13 days
| 5 |
|
|
7.4 |
null |
0.05 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104438 |
2948 |
SS-Kcnj1em1Kasu-/- |
blood urea nitrogen level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood urea nitrogen amount |
male |
13 days
| 5 |
|
|
200.32 |
mg/dl |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104441 |
2948 |
Crl:LE |
plasma creatinine level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood creatinine amount |
male |
91 days
| 5 |
|
|
0.3 |
mg/dl |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104335 |
2947 |
LE-Lrrk2em1Sage-/- |
plasma creatinine level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood creatinine amount |
male |
91 days
| 5 |
|
|
0.4 |
mg/dl |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104336 |
2947 |
LE-Lrrk2em1Sage-/- |
plasma albumin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood albumin amount |
male |
91 days
| 5 |
|
|
0.38 |
g/l |
0.0 |
0.01 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104344 |
2947 |
Crl:LE |
plasma potassium level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood potassium amount |
male |
91 days
| 5 |
|
|
7.4 |
mmol/l |
0.31 |
0.7 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104345 |
2947 |
Crl:LE |
plasma chloride level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood chloride amount |
male |
91 days
| 5 |
|
|
99.9 |
mmol/l |
0.45 |
1.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104347 |
2947 |
Crl:LE |
plasma sodium level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood sodium amount |
male |
91 days
| 5 |
|
|
144.0 |
mmol/l |
0.49 |
1.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104349 |
2947 |
LE-Lrrk2em1Sage-/- |
plasma sodium level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood sodium amount |
male |
91 days
| 5 |
|
|
146.0 |
mmol/l |
0.89 |
2.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104350 |
2947 |
LE-Lrrk2em1Sage-/- |
white blood cell count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
leukocyte quantity |
male |
91 days
| 5 |
|
|
7.5 |
x 1000 cells/ul |
0.45 |
1.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104354 |
2947 |
GK/MolTac |
blood hemoglobin A1c level |
sleeve gastrectomy (for 126 days) |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
blood glucose amount |
male |
224 days
| 10 |
|
|
4.8 |
% |
0.3 |
0.95 |
automated blood analysis |
|
0.0 |
105 |
days |
|
|
110759 |
3183 |
F344/NHsd |
hematocrit |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
erythrocyte quantity |
female |
56 days-98 days |
8 |
|
|
37.6 |
% |
2.76 |
7.8 |
automated blood analysis |
|
0.0 |
0 |
|
Anilytics |
|
13165 |
332 |
SHR.SS-(D13Rat1-D13Mgh6)/Mco |
serum albumin level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood albumin amount |
male |
84 days
| 8 |
|
|
3.8 |
g/dl |
0.3 |
0.85 |
automated blood analysis |
|
0 |
0 |
|
|
|
64815 |
246 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
female |
71 days-85 days |
6 |
|
|
118.67 |
U/l |
12.26 |
30.03 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85078 |
1602 |
SD |
blood aspartate aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
female |
85 days-99 days |
6 |
|
|
155.67 |
U/l |
3.85 |
9.42 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85081 |
1602 |
SD |
blood alanine aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
male |
71 days-85 days |
6 |
|
|
54.0 |
U/l |
2.2 |
5.4 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85086 |
1602 |
SD |
blood alanine aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
female |
85 days-99 days |
6 |
|
|
42.5 |
U/l |
1.15 |
2.81 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85092 |
1602 |
SD |
blood alkaline phosphatase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
male |
71 days-85 days |
6 |
|
|
295.8 |
U/l |
32.68 |
80.04 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85098 |
1602 |
SD |
blood alkaline phosphatase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
female |
71 days-85 days |
6 |
|
|
423.17 |
U/l |
20.15 |
49.35 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85104 |
1602 |
F344/NHsd |
blood monocyte count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
monocyte quantity |
female |
56 days-98 days |
8 |
|
|
0.51 |
x 1000 cells/ul |
0.14 |
0.4 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68384 |
332 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
female |
90 days
| 11 |
|
|
0.78 |
mmol/l |
0.06 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68428 |
69 |
SD |
blood glucose level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
71 days-85 days |
6 |
|
|
127.0 |
mg/dl |
8.82 |
21.6 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84989 |
1602 |
SD |
blood glucose level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
85 days-99 days |
6 |
|
|
62.11 |
mg/dl |
13.41 |
32.84 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84992 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
85 days-99 days |
6 |
|
|
0.77 |
null |
0.15 |
0.36 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85051 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
71 days-85 days |
6 |
|
|
1.0 |
null |
0.05 |
0.13 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85056 |
1602 |
SD |
blood creatinine level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
male |
71 days-85 days |
6 |
|
|
0.5 |
mg/dl |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85059 |
1602 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
male |
84 days
| 17 |
|
|
127.41 |
mg/dl |
2.53 |
10.42 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70101 |
324 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
female |
84 days
| 15 |
|
|
176.99 |
mg/dl |
16.91 |
65.49 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70106 |
324 |
SD |
blood total cholesterol level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
female |
71 days-85 days |
6 |
|
|
102.5 |
mg/dl |
1.84 |
4.51 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85173 |
1602 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
133 days
| 19 |
|
|
134.0 |
mg/dl |
1.15 |
5.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85332 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
168 days
| 19 |
|
|
0.43 |
mg/dl |
0.0 |
0.01 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85376 |
1604 |
SD-Fhem1+/+ |
blood urea nitrogen level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood urea nitrogen amount |
male |
0 days
| 3 |
|
|
780.0 |
mg/dl |
28.87 |
50.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104969 |
2989 |
SD |
blood potassium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
male |
71 days-85 days |
6 |
|
|
5.4 |
mmol/l |
0.11 |
0.26 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85134 |
1602 |
SD-Fhem1+/+ |
mean corpuscular volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
0 days
| 3 |
|
|
50.3 |
fl |
0.52 |
0.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104873 |
2989 |
SD-Fhem1+/- |
blood lymphocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
female |
0 days
| 3 |
|
|
1.8 |
x 1000 cells/ul |
0.29 |
0.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104900 |
2989 |
SD-Fhem1+/+ |
plasma direct bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
female |
0 days
| 3 |
|
|
0.4 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104946 |
2989 |
SD-Fhem1+/- |
plasma indirect bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
male |
0 days
| 3 |
|
|
-0.6 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104951 |
2989 |
LE-Lrrk2em1Sage-/- |
plasma potassium level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood potassium amount |
male |
91 days
| 5 |
|
|
6.5 |
mmol/l |
0.54 |
1.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104346 |
2947 |
SS/NEisSlc |
serum uric acid level |
controlled sodium content diet (8 %) (for 42 days) then cilazapril (10 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood uric acid amount |
male |
91 days
| 6 |
|
|
0.03 |
umol/l |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
100685 |
2519 |
SD |
blood triglyceride level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
female |
71 days-85 days |
6 |
|
|
22.8 |
mg/dl |
2.33 |
5.71 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85185 |
1602 |
Crl:CD(SD) |
plasma creatinine level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
70 days
| 19 |
|
|
0.41 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85370 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
147 days
| 19 |
|
|
55.4 |
U/l |
2.25 |
9.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85422 |
1604 |
SS/Jr |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
2.8 |
mg/dl |
0.11 |
0.31 |
automated blood analysis |
|
0 |
0 |
|
|
|
65784 |
246 |
SS.SHR-(D8Uia1-D8Rat90)/Mco |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
2.2 |
mg/dl |
0.08 |
0.23 |
automated blood analysis |
|
0 |
0 |
|
|
|
65785 |
246 |
SS.SHR-(D13Rat63-D13Mit1)/Mco |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
2.4 |
mg/dl |
0.12 |
0.34 |
automated blood analysis |
|
0 |
0 |
|
|
|
65786 |
246 |
BB.SHR-(D6Rat184-D6Rat3)/K |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood glucose amount |
both |
84 days
| 46 |
|
|
106.0 |
mg/dl |
2.36 |
16.0 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
12979 |
324 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
female |
84 days
| 24 |
|
|
106.2 |
mg/dl |
9.57 |
46.9 |
automated blood analysis |
opthalmic venous plexus |
|
0 |
|
|
|
12988 |
324 |
SS/Jr |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
28 days-84 days |
8 |
|
|
66.0 |
mg/dl |
4.1 |
11.6 |
automated blood analysis |
|
|
0 |
|
|
|
12399 |
246 |
SS.SHR-(D8Uia1-D8Rat90)/Mco |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
28 days-84 days |
8 |
|
|
45.0 |
mg/dl |
1.4 |
3.96 |
automated blood analysis |
|
|
0 |
|
|
|
12400 |
246 |
SHR/NHsd |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
28 days-84 days |
8 |
|
|
51.0 |
mg/dl |
3.7 |
10.47 |
automated blood analysis |
|
0 |
0 |
|
|
|
12402 |
246 |
SHR.SS-(D8Uia1-D8Rat90)/Mco |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
28 days-84 days |
8 |
|
|
44.0 |
mg/dl |
2.4 |
6.79 |
automated blood analysis |
|
|
0 |
|
|
|
12403 |
246 |
SHR.SS-(D13Rat1-D13Mgh6)/Mco |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
84 days
| 8 |
|
|
47.0 |
mg/dl |
5.3 |
14.99 |
automated blood analysis |
|
0 |
0 |
|
|
|
12404 |
246 |
WOKW |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood triglyceride amount |
female |
196 days-224 days |
12 |
|
serial mean |
44.25 |
mg/dl |
|
|
automated blood analysis |
ophthalmic venous plexus |
0.0 |
0 |
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
12428 |
251 |
BN/Crl |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
male |
90 days
| 29 |
|
|
61.78 |
mg/dl |
1.16 |
6.24 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67895 |
69 |
BB/OK |
serum triglyceride level |
control condition |
Kovacs P and Kloting I, Arch Biochem Biophys 1998 Jun 1;354(1):139-43. |
blood triglyceride amount |
male |
84 days
| 0 |
|
|
132.74 |
mg/dl |
|
53.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68959 |
1034 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
female |
90 days
| 11 |
|
|
57.14 |
mg/dl |
1.54 |
5.12 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68418 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
male |
90 days
| 15 |
|
|
1.14 |
mmol/l |
0.04 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68432 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
female |
90 days
| 14 |
|
|
1.32 |
mmol/l |
0.04 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68437 |
69 |
BN/Crl |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
male |
90 days
| 26 |
|
|
15.44 |
mg/dl |
1.16 |
5.91 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68451 |
69 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
male |
90 days
| 13 |
|
|
11.58 |
mg/dl |
0.77 |
2.78 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68453 |
69 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
female |
90 days
| 11 |
|
|
8.88 |
mg/dl |
0.77 |
2.56 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68458 |
69 |
BN/Crl |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
male |
90 days
| 23 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
20.46 |
mg/dl |
1.16 |
5.56 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68461 |
69 |
BN/Crl |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
female |
90 days
| 20 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
24.71 |
mg/dl |
1.16 |
5.18 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68466 |
69 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
female |
90 days
| 11 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
18.53 |
mg/dl |
1.54 |
5.12 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68468 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
female |
90 days
| 6 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
19.69 |
mg/dl |
2.32 |
5.67 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68470 |
69 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma creatinine level |
left nephrectomy |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175 days
| 19 |
|
|
0.59 |
mg/dl |
0.01 |
0.06 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67763 |
110 |
BB.SHR-(D6Rat184-D6Rat3)/K |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood glucose amount |
both |
84 days
| 32 |
|
|
105.0 |
mg/dl |
1.77 |
10.0 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70110 |
324 |
BB.SHR-(Gnal-D18Mit9)/K |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood glucose amount |
both |
84 days
| 25 |
|
|
107.0 |
mg/dl |
2.6 |
13.0 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70111 |
324 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
78 days
| 19 |
|
|
17.9 |
U/l |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85445 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
91 days
| 19 |
|
|
15.5 |
U/l |
0.62 |
2.7 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85447 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
119 days
| 19 |
|
|
15.0 |
U/l |
0.55 |
2.4 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85451 |
1604 |
SD |
blood sodium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
male |
71 days-85 days |
6 |
|
|
143.8 |
mmol/l |
0.6 |
1.47 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85119 |
1602 |
SD |
blood sodium level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
female |
71 days-85 days |
6 |
|
|
146.67 |
mmol/l |
0.49 |
1.21 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85127 |
1602 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
133 days
| 19 |
|
|
35.9 |
U/l |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85436 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
133 days
| 19 |
|
|
32.4 |
U/l |
0.99 |
4.3 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85437 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
147 days
| 19 |
|
|
36.4 |
U/l |
0.62 |
2.7 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85438 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
147 days
| 19 |
|
|
16.1 |
U/l |
0.69 |
3.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85454 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
168 days
| 19 |
|
|
14.3 |
U/l |
0.8 |
3.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85456 |
1604 |
BB.SHR-(Gnal-D18Mit9)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
male |
84 days
| 15 |
|
|
159.29 |
mg/dl |
9.83 |
38.05 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70107 |
324 |
SD |
blood triglyceride level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
female |
71 days-85 days |
6 |
|
|
27.7 |
mg/dl |
2.83 |
6.92 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85186 |
1602 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
70 days
| 19 |
|
|
0.57 |
mg/dl |
0.04 |
0.18 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85339 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
78 days
| 19 |
|
|
0.69 |
mg/dl |
0.15 |
0.64 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85341 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
119 days
| 19 |
|
|
33.2 |
mg/dl |
3.4 |
14.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85363 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
147 days
| 19 |
|
|
17.0 |
mg/dl |
1.24 |
5.4 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85366 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
168 days
| 19 |
|
|
0.46 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85377 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
70 days
| 19 |
|
|
60.7 |
U/l |
1.19 |
5.2 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85410 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
91 days
| 19 |
|
|
59.7 |
U/l |
0.8 |
3.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85415 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
105 days
| 19 |
|
|
34.9 |
U/l |
1.1 |
4.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85432 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
119 days
| 19 |
|
|
37.8 |
U/l |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85434 |
1604 |
WOKW/K |
blood glucose level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood glucose amount |
not specified |
196 days-224 days |
12 |
|
|
94.0 |
mg/dl |
1.73 |
6.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
96848 |
1123 |
FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
plasma creatinine level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood creatinine amount |
male |
189 days
| 9 |
|
|
0.54 |
mg/dl |
0.05 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
ACE Autoanalyzer Clinical Chemistry System |
|
96917 |
1738 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
71 days-85 days |
6 |
|
|
1.1 |
null |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85055 |
1602 |
SD |
blood creatinine level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
female |
85 days-99 days |
6 |
|
|
0.33 |
mg/dl |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85069 |
1602 |
SD |
blood alanine aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
female |
85 days-99 days |
6 |
|
|
49.67 |
U/l |
2.17 |
5.32 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85093 |
1602 |
SD |
blood potassium level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
female |
71 days-85 days |
6 |
|
|
4.6 |
mmol/l |
0.1 |
0.25 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85138 |
1602 |
SD |
blood phosphate level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
female |
71 days-85 days |
6 |
|
|
5.98 |
mg/dl |
0.33 |
0.82 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85163 |
1602 |
SD |
blood phosphate level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
female |
85 days-99 days |
6 |
|
|
5.5 |
mg/dl |
0.15 |
0.37 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85166 |
1602 |
SD |
blood calcium level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
female |
71 days-85 days |
6 |
|
|
10.0 |
mg/dl |
0.04 |
0.09 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85151 |
1602 |
SD |
blood phosphate level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
female |
85 days-99 days |
6 |
|
|
5.45 |
mg/dl |
0.26 |
0.63 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85165 |
1602 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
70 days
| 19 |
|
|
143.0 |
mg/dl |
1.38 |
6.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85322 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
133 days
| 19 |
|
|
0.91 |
mg/dl |
0.1 |
0.43 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85349 |
1604 |
SD |
blood globulin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
female |
71 days-85 days |
6 |
|
|
3.0 |
g/dl |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85029 |
1602 |
SD |
blood globulin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
female |
71 days-85 days |
6 |
|
|
3.8 |
g/dl |
0.21 |
0.51 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85032 |
1602 |
SD |
blood alkaline phosphatase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
female |
71 days-85 days |
6 |
|
|
206.0 |
U/l |
27.48 |
67.31 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85101 |
1602 |
SD |
blood alkaline phosphatase activity level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
female |
71 days-85 days |
6 |
|
|
416.5 |
U/l |
68.13 |
166.88 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85103 |
1602 |
SD |
blood bilirubin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
female |
71 days-85 days |
6 |
|
|
1.33 |
mg/dl |
0.2 |
0.49 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85116 |
1602 |
SD |
blood bilirubin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
female |
85 days-99 days |
6 |
|
|
0.63 |
mg/dl |
0.04 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85118 |
1602 |
Hsd:WI |
plasma aspartate aminotransferase activity level |
fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood aspartate transaminase amount |
not specified |
0 days
| 10 |
|
|
155.6 |
U/l |
9.58 |
30.3 |
automated blood analysis |
|
0.0 |
0 |
|
Architect c16000; Abbott Laboratories, USA |
|
85594 |
1618 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
70 days
| 19 |
|
|
117.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85323 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
168 days
| 19 |
|
|
0.56 |
mg/dl |
0.03 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85353 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
168 days
| 19 |
|
|
18.9 |
mg/dl |
1.67 |
7.3 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85369 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
70 days
| 19 |
|
|
0.38 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85371 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
119 days
| 19 |
|
|
58.8 |
U/l |
1.54 |
6.7 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85419 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
133 days
| 19 |
|
|
57.6 |
U/l |
1.58 |
6.9 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85421 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
91 days
| 19 |
|
|
33.3 |
U/l |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85430 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
119 days
| 19 |
|
|
127.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85331 |
1604 |
SD |
blood glucose level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
71 days-85 days |
6 |
|
|
103.7 |
mg/dl |
5.52 |
13.52 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84988 |
1602 |
SD |
blood glucose level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
71 days-85 days |
6 |
|
|
70.7 |
mg/dl |
4.78 |
11.71 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84993 |
1602 |
SD |
blood albumin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
85 days-99 days |
6 |
|
|
2.93 |
g/dl |
0.55 |
1.35 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85003 |
1602 |
SD |
blood total cholesterol level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
male |
71 days-85 days |
6 |
|
|
92.8 |
mg/dl |
6.06 |
14.84 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85168 |
1602 |
SS/NEisSlc |
serum uric acid level |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood uric acid amount |
male |
91 days
| 6 |
|
|
0.02 |
umol/l |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
100683 |
2519 |
Crl:LE |
mean corpuscular hemoglobin |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood hemoglobin amount |
male |
91 days
| 5 |
|
|
18.9 |
pg |
0.36 |
0.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104363 |
2947 |
Crl:LE |
blood basophil count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
basophil quantity |
male |
91 days
| 5 |
|
|
0.0 |
% |
|
|
automated blood analysis |
|
0.0 |
0 |
|
|
|
104375 |
2947 |
LE-Lrrk2em1Sage-/- |
blood lymphocyte count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lymphocyte quantity |
male |
91 days
| 5 |
|
|
6.33 |
x 1000 cells/ul |
0.41 |
0.91 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104380 |
2947 |
SD-Fhem1+/+ |
mean corpuscular volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
female |
0 days
| 3 |
|
|
55.6 |
fl |
1.96 |
3.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104874 |
2989 |
SD-Fhem1+/- |
blood monocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
male |
0 days
| 3 |
|
|
0.4 |
x 1000 cells/ul |
0.29 |
0.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104903 |
2989 |
SD-Fhem1+/- |
blood eosinophil count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
female |
0 days
| 3 |
|
|
0.03 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104908 |
2989 |
SD-Fhem1+/- |
red blood cell distribution width- standard deviation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
female |
0 days
| 3 |
|
|
25.6 |
% |
0.69 |
1.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104912 |
2989 |
SD-Fhem1+/+ |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
female |
0 days
| 3 |
|
|
14.6 |
% |
1.91 |
3.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104914 |
2989 |
SD-Fhem1+/- |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
0 days
| 3 |
|
|
19.6 |
% |
0.81 |
1.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104915 |
2989 |
Crl:LE |
blood segmented neutrophil count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
neutrophil quantity |
male |
91 days
| 5 |
|
|
12.6 |
% |
1.97 |
4.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104367 |
2947 |
Crl:LE |
blood urea nitrogen level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood urea nitrogen amount |
male |
91 days
| 5 |
|
|
17.8 |
mg/dl |
0.58 |
1.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104327 |
2947 |
LE-Lrrk2em1Sage-/- |
blood urea nitrogen level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood urea nitrogen amount |
male |
91 days
| 5 |
|
|
18.8 |
mg/dl |
1.48 |
3.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104328 |
2947 |
SD-Fhem1+/+ |
mean corpuscular hemoglobin concentration |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
0 days
| 3 |
|
|
3303.0 |
g/dl |
42.15 |
73.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104882 |
2989 |
SD-Fhem1+/- |
mean corpuscular hemoglobin concentration |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
male |
0 days
| 3 |
|
|
3443.0 |
g/dl |
23.67 |
41.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104883 |
2989 |
SD-Fhem1+/- |
blood monocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
monocyte quantity |
female |
0 days
| 3 |
|
|
3.6 |
% |
0.46 |
0.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104892 |
2989 |
SD-Fhem1+/+ |
blood eosinophil count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
female |
0 days
| 3 |
|
|
2.1 |
% |
0.52 |
0.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104894 |
2989 |
SD-Fhem1+/- |
blood eosinophil count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
female |
0 days
| 3 |
|
|
1.0 |
% |
0.06 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104896 |
2989 |
SD-Fhem1+/+ |
blood alanine aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood alanine transaminase amount |
male |
0 days
| 3 |
|
|
47.3 |
U/l |
1.79 |
3.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104925 |
2989 |
SD-Fhem1+/+ |
blood gamma-glutamyltransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood gamma-glutamyltransferase amount |
female |
0 days
| 3 |
|
|
1.0 |
U/l |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104934 |
2989 |
LE-Lrrk2em1Sage-/- |
blood alkaline phosphatase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood alkaline phosphatase amount |
male |
91 days
| 5 |
|
|
204.0 |
U/l |
10.51 |
23.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104322 |
2947 |
Crl:LE |
blood alanine aminotransferase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood alanine transaminase amount |
male |
91 days
| 5 |
|
|
75.2 |
U/l |
3.4 |
7.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104323 |
2947 |
SD-Fhem1+/+ |
blood creatine kinase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood creatine kinase amount |
male |
0 days
| 3 |
|
|
36.7 |
IU/l |
4.39 |
7.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104981 |
2989 |
LE-Lrrk2em1Sage-/- |
blood lymphocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lymphocyte quantity |
male |
91 days
| 5 |
|
|
83.8 |
% |
0.98 |
2.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104370 |
2947 |
SS-Kcnj1em1Kasu+/- |
blood sodium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood sodium amount |
male |
13 days
| 6 |
|
|
127.7 |
mmol/l |
0.6 |
1.47 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104425 |
2948 |
SS-Kcnj1em1Kasu-/- |
blood sodium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood sodium amount |
male |
13 days
| 5 |
|
|
148.2 |
mmol/l |
1.7 |
3.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104426 |
2948 |
SS-Kcnj1em1Kasu-/- |
blood bicarbonate level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood bicarbonate amount |
male |
13 days
| 5 |
|
|
21.6 |
mmol/l |
1.2 |
2.68 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104435 |
2948 |
SS-Kcnj1em1Kasu+/+ |
blood urea nitrogen level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood urea nitrogen amount |
male |
13 days
| 6 |
|
|
35.07 |
mg/dl |
4.57 |
11.19 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104439 |
2948 |
Crl:LE |
red blood cell count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
erythrocyte quantity |
male |
91 days
| 5 |
|
|
8.6 |
x 10E6 cells/ul |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104355 |
2947 |
LE-Lrrk2em1Sage-/- |
red blood cell count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
erythrocyte quantity |
male |
91 days
| 5 |
|
|
7.8 |
x 10E6 cells/ul |
0.13 |
0.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104356 |
2947 |
SHR/Mol |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood triglyceride amount |
female |
84 days-98 days |
12 |
|
|
150.44 |
mg/dl |
5.11 |
17.7 |
automated blood analysis |
opthalmic plexus |
|
0 |
|
mean of samples at 12, 13 and 14 weeks |
|
12933 |
323 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
female |
84 days
| 24 |
|
|
104.25 |
mg/dl |
1.34 |
6.56 |
automated blood analysis |
opthalmic venous plexus |
|
0 |
|
|
|
12983 |
324 |
SS.SHR-(D8Uia1-D8Rat90)/Mco |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
95.0 |
mg/dl |
2.8 |
7.92 |
automated blood analysis |
|
0 |
0 |
|
|
|
64813 |
246 |
SD |
blood alanine aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
female |
71 days-85 days |
6 |
|
|
46.83 |
U/l |
2.69 |
6.59 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85089 |
1602 |
SD |
blood alkaline phosphatase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
male |
71 days-85 days |
6 |
|
|
298.5 |
U/l |
41.58 |
101.85 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85095 |
1602 |
F344/NHsd |
total white blood cell count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
leukocyte quantity |
female |
56 days-98 days |
8 |
|
|
10.9 |
x 1000 cells/ul |
1.52 |
4.3 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68378 |
332 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
female |
90 days
| 6 |
|
|
59.85 |
mg/dl |
3.47 |
8.51 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68420 |
69 |
BN/Crl |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
male |
90 days
| 20 |
|
|
1.14 |
mmol/l |
0.04 |
0.18 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68431 |
69 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71 days-85 days |
6 |
|
|
0.9 |
null |
0.03 |
0.07 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85048 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
71 days-85 days |
6 |
|
|
0.9 |
null |
0.02 |
0.06 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85053 |
1602 |
WKY/NCruk |
plasma urea nitrogen level |
left nephrectomy |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood urea nitrogen amount |
male |
175 days
| 20 |
|
|
6.28 |
mmol/l |
0.23 |
1.03 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67754 |
110 |
WKY/NCruk |
plasma creatinine level |
left nephrectomy |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175 days
| 20 |
|
|
0.61 |
mg/dl |
0.02 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67762 |
110 |
F344/DuCrlCrlj |
plasma triglyceride level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood triglyceride amount |
male |
112 days
| 15 |
|
|
0.55 |
mmol/l |
0.03 |
0.13 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68964 |
1035 |
SD |
blood phosphate level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
male |
71 days-85 days |
6 |
|
|
6.3 |
mg/dl |
0.07 |
0.18 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85155 |
1602 |
SD |
blood triglyceride level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
male |
71 days-85 days |
6 |
|
|
92.3 |
mg/dl |
21.39 |
52.39 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85182 |
1602 |
SD-Fhem1+/- |
hematocrit |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte quantity |
male |
0 days
| 3 |
|
|
42.1 |
% |
0.92 |
1.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104859 |
2989 |
SD-Fhem1+/+ |
platelet count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet quantity |
female |
0 days
| 3 |
|
|
1152.3 |
x 1000 /ul |
118.82 |
205.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104862 |
2989 |
SD-Fhem1+/+ |
mean platelet volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
male |
0 days
| 3 |
|
|
8.7 |
fl |
0.17 |
0.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104865 |
2989 |
SD-Fhem1+/- |
blood eosinophil count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
male |
0 days
| 3 |
|
|
0.04 |
x 1000 cells/ul |
0.03 |
0.06 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104907 |
2989 |
SD-Fhem1+/+ |
red blood cell distribution width- standard deviation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
0 days
| 3 |
|
|
25.5 |
% |
0.29 |
0.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104909 |
2989 |
SD-Fhem1+/- |
blood aspartate aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood aspartate transaminase amount |
male |
0 days
| 3 |
|
|
124.3 |
U/l |
5.6 |
9.7 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104931 |
2989 |
SD-Fhem1+/+ |
blood gamma-glutamyltransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood gamma-glutamyltransferase amount |
male |
0 days
| 3 |
|
|
1.3 |
U/l |
0.35 |
0.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104933 |
2989 |
SD-Fhem1+/- |
blood gamma-glutamyltransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood gamma-glutamyltransferase amount |
male |
0 days
| 3 |
|
|
1.3 |
U/l |
0.35 |
0.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104935 |
2989 |
Crl:LE |
white blood cell count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
leukocyte quantity |
male |
91 days
| 5 |
|
|
9.5 |
x 1000 cells/ul |
0.54 |
1.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104353 |
2947 |
SD-Fhem1+/+ |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
male |
0 days
| 3 |
|
|
147.6 |
mg/dl |
3.12 |
5.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104965 |
2989 |
SD-Fhem1+/- |
blood urea nitrogen level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood urea nitrogen amount |
male |
0 days
| 3 |
|
|
810.0 |
mg/dl |
28.87 |
50.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104971 |
2989 |
SD-Fhem1+/- |
blood uric acid level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood uric acid amount |
female |
0 days
| 3 |
|
|
2.83 |
mg/dl |
0.13 |
0.22 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104976 |
2989 |
SD-Fhem1+/+ |
blood creatine kinase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood creatine kinase amount |
female |
0 days
| 3 |
|
|
35.0 |
IU/l |
1.5 |
2.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104982 |
2989 |
SD |
blood potassium level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
female |
71 days-85 days |
6 |
|
|
4.75 |
mmol/l |
0.22 |
0.54 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85139 |
1602 |
LE-Lrrk2em1Sage-/- |
hematocrit |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
erythrocyte quantity |
male |
91 days
| 5 |
|
|
48.1 |
% |
0.76 |
1.7 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104360 |
2947 |
Crl:LE |
blood lymphocyte count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lymphocyte quantity |
male |
91 days
| 5 |
|
|
7.99 |
x 1000 cells/ul |
0.35 |
0.79 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104379 |
2947 |
SD |
blood total cholesterol level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
female |
71 days-85 days |
6 |
|
|
92.2 |
mg/dl |
5.71 |
13.98 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85174 |
1602 |
SD |
blood triglyceride level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
female |
85 days-99 days |
6 |
|
|
23.83 |
mg/dl |
1.49 |
3.66 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85190 |
1602 |
SD |
blood calcium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
male |
85 days-99 days |
6 |
|
|
8.27 |
mg/dl |
1.63 |
4.0 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85147 |
1602 |
SD |
blood calcium level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
female |
71 days-85 days |
6 |
|
|
10.05 |
mg/dl |
0.08 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85150 |
1602 |
SD |
blood phosphate level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
female |
71 days-85 days |
6 |
|
|
5.6 |
mg/dl |
0.13 |
0.32 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85161 |
1602 |
SD |
blood total cholesterol level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
female |
85 days-99 days |
6 |
|
|
109.17 |
mg/dl |
4.94 |
12.09 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85178 |
1602 |
SS.ZUC-Leprfa-/-/Slc |
serum aspartate aminotransferase activity level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood aspartate transaminase amount |
male |
126 days
| 7 |
|
|
67.33 |
U/l |
4.67 |
12.36 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101928 |
2642 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
91 days
| 19 |
|
|
135.0 |
mg/dl |
1.15 |
5.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85326 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
105 days
| 19 |
|
|
129.0 |
mg/dl |
1.38 |
6.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85328 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
147 days
| 19 |
|
|
0.68 |
mg/dl |
0.1 |
0.42 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85351 |
1604 |
F344/NHsd |
mean corpuscular hemoglobin concentration |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
blood hemoglobin amount |
female |
56 days-98 days |
8 |
|
|
36.7 |
g/dl |
0.64 |
1.8 |
automated blood analysis |
|
0.0 |
0 |
|
Anilytics |
|
13172 |
332 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
male |
84 days
| 22 |
|
|
88.8 |
mg/dl |
1.89 |
8.88 |
automated blood analysis |
opthalmic venous plexus |
|
0 |
|
|
|
12982 |
324 |
SHR.SS-(D13Rat1-D13Mgh6)/Mco |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
40.0 |
mg/dl |
1.8 |
5.09 |
automated blood analysis |
|
0 |
0 |
|
|
|
64809 |
246 |
SS.SHR-(D13Rat63-D13Mit1)/Mco |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
102.0 |
mg/dl |
13.3 |
37.62 |
automated blood analysis |
|
0 |
0 |
|
|
|
64812 |
246 |
OLETF/Got |
plasma triglyceride level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood triglyceride amount |
male |
112 days
| 25 |
|
|
1.27 |
mmol/l |
0.06 |
0.29 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68963 |
1035 |
BN/Crl |
plasma glucose level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood glucose amount |
male |
60 days
| 6 |
|
|
127.8 |
mg/dl |
3.06 |
7.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
mM |
68772 |
1012 |
BN/Crl |
plasma glucose level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood glucose amount |
female |
60 days
| 6 |
|
|
129.96 |
mg/dl |
3.96 |
9.7 |
automated blood analysis |
|
0.0 |
0 |
|
automated plasma glucose analysis |
mM |
68773 |
1012 |
OLETF/Got |
plasma free fatty acids level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood free fatty acid amount |
male |
112 days
| 25 |
|
|
1.0 |
mmol/l |
0.03 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
|
"mEq/l" can not be converted to CMO:0000546's standard unit: "mmol/l" |
68968 |
1035 |
DA/BklArbNsi |
total white blood cell count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
leukocyte quantity |
female |
56 days-98 days |
7 |
|
|
10.8 |
x 1000 cells/ul |
1.02 |
2.7 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68377 |
332 |
F344/NHsd |
blood neutrophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
neutrophil quantity |
female |
56 days-98 days |
8 |
|
|
2.72 |
x 1000 cells/ul |
0.35 |
1.0 |
automated blood analysis |
heart or retroorbital sinus |
0.0 |
0 |
|
Anilytics |
|
68380 |
332 |
DA/BklArbNsi |
blood eosinophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eosinophil quantity |
female |
56 days-98 days |
7 |
|
|
0.35 |
x 1000 cells/ul |
0.08 |
0.2 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68385 |
332 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
male |
90 days
| 10 |
|
|
66.8 |
mg/dl |
1.54 |
4.88 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68415 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
female |
90 days
| 6 |
|
|
70.27 |
mg/dl |
2.7 |
6.62 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68419 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
male |
90 days
| 16 |
|
|
29.34 |
mg/dl |
1.16 |
4.63 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68442 |
69 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
male |
90 days
| 15 |
|
|
26.64 |
mg/dl |
1.16 |
4.49 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68443 |
69 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
female |
90 days
| 11 |
|
|
29.73 |
mg/dl |
0.77 |
2.56 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68448 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
male |
90 days
| 10 |
|
|
12.74 |
mg/dl |
0.39 |
1.22 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68455 |
69 |
BN/Crl |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
female |
90 days
| 20 |
|
|
8.49 |
mg/dl |
0.39 |
1.73 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68456 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
male |
90 days
| 10 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
22.78 |
mg/dl |
1.93 |
6.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68464 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
female |
90 days
| 6 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
25.87 |
mg/dl |
2.32 |
5.67 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68469 |
69 |
WKY/NCruk |
plasma urea nitrogen level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood urea nitrogen amount |
male |
175 days
| 19 |
|
|
5.2 |
mmol/l |
0.32 |
1.39 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67752 |
110 |
WKY/NCruk |
plasma creatinine level |
left nephrectomy and left kidney transplant then right nephrectomy |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175 days
| 20 |
|
|
0.61 |
mg/dl |
0.02 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67765 |
110 |
SD |
blood bilirubin level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
female |
71 days-85 days |
6 |
|
|
0.34 |
mg/dl |
0.02 |
0.06 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85114 |
1602 |
SD |
blood sodium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
male |
85 days-99 days |
6 |
|
|
123.26 |
mmol/l |
24.32 |
59.56 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85123 |
1602 |
SD |
blood sodium level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
female |
71 days-85 days |
6 |
|
|
146.67 |
mmol/l |
0.62 |
1.51 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85126 |
1602 |
SD |
blood calcium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
female |
85 days-99 days |
6 |
|
|
10.08 |
mg/dl |
0.1 |
0.25 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85154 |
1602 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
female |
84 days
| 15 |
|
|
123.55 |
mg/dl |
2.29 |
8.88 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70102 |
324 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
male |
84 days
| 17 |
|
|
132.74 |
mg/dl |
9.01 |
37.17 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70105 |
324 |
BB.SHR-(Gnal-D18Mit9)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
female |
84 days
| 10 |
|
|
168.14 |
mg/dl |
20.99 |
66.37 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70108 |
324 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
168 days
| 19 |
|
|
48.1 |
U/l |
0.69 |
3.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85425 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
133 days
| 19 |
|
|
13.4 |
U/l |
0.3 |
1.3 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85453 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
78 days
| 19 |
|
|
130.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85324 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
147 days
| 19 |
|
|
129.0 |
mg/dl |
0.92 |
4.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85334 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
78 days
| 19 |
|
|
21.1 |
mg/dl |
1.08 |
4.7 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85356 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
91 days
| 19 |
|
|
18.8 |
mg/dl |
0.53 |
2.3 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85358 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
70 days
| 19 |
|
|
61.8 |
U/l |
1.26 |
5.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85411 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
105 days
| 19 |
|
|
58.0 |
U/l |
2.39 |
10.4 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85416 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
105 days
| 19 |
|
|
34.0 |
U/l |
1.35 |
5.9 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85433 |
1604 |
Crl:CD(SD) |
blood urea nitrogen level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood urea nitrogen amount |
male |
189 days
| 6 |
|
|
22.33 |
mg/dl |
1.53 |
3.75 |
automated blood analysis |
|
0.0 |
0 |
|
ACE Autoanalyzer Clinical Chemistry System |
|
96906 |
1738 |
SD |
blood glucose level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
85 days-99 days |
6 |
|
|
72.48 |
mg/dl |
12.78 |
31.31 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84991 |
1602 |
SD |
blood urea nitrogen level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
male |
71 days-85 days |
6 |
|
|
16.0 |
mg/dl |
0.93 |
2.28 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85035 |
1602 |
SD |
blood urea nitrogen level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
male |
71 days-85 days |
6 |
|
|
14.5 |
mg/dl |
0.72 |
1.76 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85036 |
1602 |
SD |
blood urea nitrogen level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
male |
85 days-99 days |
6 |
|
|
13.56 |
mg/dl |
2.41 |
5.9 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85039 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71 days-85 days |
6 |
|
|
0.9 |
null |
0.01 |
0.03 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85049 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
85 days-99 days |
6 |
|
|
0.97 |
null |
0.04 |
0.09 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85058 |
1602 |
SD |
blood creatinine level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
male |
71 days-85 days |
6 |
|
|
0.4 |
mg/dl |
0.02 |
0.06 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85060 |
1602 |
SD |
blood creatinine level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
male |
85 days-99 days |
6 |
|
|
0.37 |
mg/dl |
0.07 |
0.16 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85063 |
1602 |
SD |
blood creatinine level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
female |
85 days-99 days |
6 |
|
|
0.33 |
mg/dl |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85070 |
1602 |
SD |
blood aspartate aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
female |
71 days-85 days |
6 |
|
|
162.23 |
U/l |
8.83 |
21.64 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85077 |
1602 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
female |
71 days-85 days |
6 |
|
|
263.17 |
U/l |
34.35 |
84.13 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85080 |
1602 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
female |
85 days-99 days |
6 |
|
|
146.5 |
U/l |
7.35 |
18.01 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85082 |
1602 |
SD |
blood alanine aminotransferase activity level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
female |
71 days-85 days |
6 |
|
|
57.33 |
U/l |
1.33 |
3.27 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85090 |
1602 |
SD |
blood alkaline phosphatase activity level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
male |
71 days-85 days |
6 |
|
|
327.2 |
U/l |
66.05 |
161.8 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85097 |
1602 |
SD |
blood bilirubin level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
male |
71 days-85 days |
6 |
|
|
0.41 |
mg/dl |
0.04 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85108 |
1602 |
SD |
blood potassium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
male |
85 days-99 days |
6 |
|
|
4.6 |
mmol/l |
0.87 |
2.14 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85135 |
1602 |
SD |
blood potassium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
male |
85 days-99 days |
6 |
|
|
3.88 |
mmol/l |
0.9 |
2.2 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85136 |
1602 |
SD |
blood triglyceride level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
male |
85 days-99 days |
6 |
|
|
65.45 |
mg/dl |
8.04 |
19.69 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85183 |
1602 |
SD |
blood triglyceride level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
male |
85 days-99 days |
6 |
|
|
58.81 |
mg/dl |
10.11 |
24.76 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85184 |
1602 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
119 days
| 19 |
|
|
0.61 |
mg/dl |
0.02 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85346 |
1604 |
SD |
blood albumin level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71 days-85 days |
6 |
|
|
3.3 |
g/dl |
0.1 |
0.25 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85000 |
1602 |
SD |
blood globulin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
male |
71 days-85 days |
6 |
|
|
2.9 |
g/dl |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85023 |
1602 |
SD |
blood globulin level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
male |
71 days-85 days |
6 |
|
|
3.0 |
g/dl |
0.05 |
0.13 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85024 |
1602 |
SD |
blood globulin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
male |
71 days-85 days |
6 |
|
|
3.0 |
g/dl |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85026 |
1602 |
SD |
blood globulin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
male |
85 days-99 days |
6 |
|
|
2.12 |
g/dl |
0.5 |
1.23 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85028 |
1602 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
male |
85 days-99 days |
6 |
|
|
125.07 |
U/l |
25.92 |
63.49 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85076 |
1602 |
SD |
blood alkaline phosphatase activity level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
female |
71 days-85 days |
6 |
|
|
353.33 |
U/l |
79.96 |
195.86 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85102 |
1602 |
SD |
blood alkaline phosphatase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
female |
85 days-99 days |
6 |
|
|
178.67 |
U/l |
18.2 |
44.59 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85105 |
1602 |
SD |
blood bilirubin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
male |
85 days-99 days |
6 |
|
|
0.55 |
mg/dl |
0.07 |
0.16 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85112 |
1602 |
SD |
blood bilirubin level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
female |
71 days-85 days |
6 |
|
|
0.39 |
mg/dl |
0.05 |
0.12 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85115 |
1602 |
Hsd:WI |
plasma aspartate aminotransferase activity level |
acetaminophen (500 mg/kg) (for 1 days) then thymoquinone (15 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood aspartate transaminase amount |
not specified |
0 days
| 10 |
|
|
185.6 |
U/l |
18.44 |
58.3 |
automated blood analysis |
|
0.0 |
0 |
|
Architect c16000; Abbott Laboratories, USA |
|
85597 |
1618 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
168 days
| 19 |
|
|
0.44 |
mg/dl |
0.01 |
0.06 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85352 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
119 days
| 19 |
|
|
14.8 |
U/l |
0.89 |
3.9 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85450 |
1604 |
Hsd:WI |
plasma alanine aminotransferase activity level |
acetaminophen (500 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood alanine transaminase amount |
not specified |
0 days
| 10 |
|
|
131.0 |
U/l |
10.37 |
32.8 |
automated blood analysis |
|
0.0 |
0 |
|
Architect c16000; Abbott Laboratories, USA |
|
85592 |
1618 |
SD |
blood glucose level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
71 days-85 days |
6 |
|
|
116.2 |
mg/dl |
9.03 |
22.13 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84995 |
1602 |
SD |
blood albumin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
85 days-99 days |
6 |
|
|
3.6 |
g/dl |
0.06 |
0.14 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85009 |
1602 |
SD |
blood total cholesterol level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
female |
85 days-99 days |
6 |
|
|
112.17 |
mg/dl |
3.51 |
8.59 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85177 |
1602 |
SD |
blood triglyceride level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
male |
71 days-85 days |
6 |
|
|
109.5 |
mg/dl |
30.43 |
74.55 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85181 |
1602 |
SD |
blood albumin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71 days-85 days |
6 |
|
|
3.3 |
g/dl |
0.05 |
0.13 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84999 |
1602 |
SR/NEisSlc |
serum uric acid level |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood uric acid amount |
male |
91 days
| 6 |
|
|
0.02 |
umol/l |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
100684 |
2519 |
SD-Fhem1+/- |
blood hemoglobin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
male |
0 days
| 3 |
|
|
1450.0 |
g/dl |
40.41 |
70.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104855 |
2989 |
SD-Fhem1+/+ |
hematocrit |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte quantity |
male |
0 days
| 3 |
|
|
43.4 |
% |
0.92 |
1.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104857 |
2989 |
SD-Fhem1+/- |
mean corpuscular volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
female |
0 days
| 3 |
|
|
51.4 |
fl |
0.64 |
1.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104876 |
2989 |
SD-Fhem1+/+ |
blood eosinophil count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
male |
0 days
| 3 |
|
|
0.06 |
x 1000 cells/ul |
0.01 |
0.01 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104905 |
2989 |
SS.ZUC-Leprfa+/+/Slc |
blood aspartate aminotransferase activity level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood aspartate transaminase amount |
male |
91 days
| 10 |
|
|
59.0 |
U/l |
7.42 |
23.46 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101858 |
2641 |
SS/NEisSlc |
serum uric acid level |
controlled sodium content diet (8 %) (for 42 days) then candesartan (1 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood uric acid amount |
male |
91 days
| 6 |
|
|
0.03 |
umol/l |
0.0 |
0.01 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
100686 |
2519 |
SD-Fhem1+/- |
blood creatine kinase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood creatine kinase amount |
male |
0 days
| 3 |
|
|
41.0 |
IU/l |
0.58 |
1.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104983 |
2989 |
SD-Fhem1+/- |
blood creatine kinase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood creatine kinase amount |
female |
0 days
| 3 |
|
|
34.5 |
IU/l |
3.23 |
5.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104984 |
2989 |
SD-Fhem1+/+ |
blood lymphocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
male |
0 days
| 3 |
|
|
58.5 |
% |
3.41 |
5.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104885 |
2989 |
SD-Fhem1+/- |
blood lymphocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
female |
0 days
| 3 |
|
|
57.8 |
% |
4.56 |
7.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104888 |
2989 |
SD-Fhem1+/- |
blood alanine aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood alanine transaminase amount |
male |
0 days
| 3 |
|
|
43.7 |
U/l |
3.29 |
5.7 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104927 |
2989 |
SD-Fhem1+/- |
blood alkaline phosphatase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood alkaline phosphatase amount |
male |
0 days
| 3 |
|
|
38.0 |
U/l |
5.43 |
9.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104940 |
2989 |
SD-Fhem1+/+ |
plasma indirect bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
male |
0 days
| 3 |
|
|
0.4 |
umol/l |
0.06 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104949 |
2989 |
Crl:LE |
mean corpuscular volume |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
erythrocyte size trait |
male |
91 days
| 5 |
|
|
61.0 |
fl |
0.45 |
1.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104361 |
2947 |
Crl:LE |
blood segmented neutrophil count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
neutrophil quantity |
male |
91 days
| 5 |
|
|
1231.0 |
cells/ul |
243.28 |
544.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104377 |
2947 |
Crl:LE |
blood eosinophil count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
eosinophil quantity |
male |
91 days
| 5 |
|
|
0.09 |
x 1000 cells/ul |
0.01 |
0.01 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104383 |
2947 |
Crl:LE |
blood aspartate aminotransferase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood aspartate transaminase amount |
male |
91 days
| 5 |
|
|
65.8 |
U/l |
3.71 |
8.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104325 |
2947 |
LE-Lrrk2em1Sage-/- |
blood aspartate aminotransferase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood aspartate transaminase amount |
male |
91 days
| 5 |
|
|
56.2 |
U/l |
1.74 |
3.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104326 |
2947 |
SS-Kcnj1em1Kasu-/- |
blood chloride level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood chloride amount |
male |
13 days
| 5 |
|
|
130.4 |
mmol/l |
2.3 |
5.14 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104432 |
2948 |
Crl:LE |
plasma total bilirubin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood bilirubin amount |
male |
91 days
| 5 |
|
|
0.6 |
mg/dl |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104339 |
2947 |
Crl:LE |
plasma calcium level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood calcium amount |
male |
91 days
| 5 |
|
|
0.38 |
mmol/l |
0.0 |
0.01 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104351 |
2947 |
SD-Fhem1+/+ |
blood urea nitrogen level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood urea nitrogen amount |
female |
0 days
| 3 |
|
|
670.0 |
mg/dl |
17.32 |
30.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104970 |
2989 |
SD-Fhem1+/- |
blood protein measurement |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood total protein amount |
female |
0 days
| 3 |
|
|
677.0 |
g/dl |
16.74 |
29.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104956 |
2989 |
SS-Kcnj1em1Kasu+/+ |
blood sodium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood sodium amount |
male |
13 days
| 6 |
|
|
129.3 |
mmol/l |
0.6 |
1.47 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104424 |
2948 |
SS-Kcnj1em1Kasu-/- |
blood potassium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood potassium amount |
male |
13 days
| 5 |
|
|
6.4 |
mmol/l |
0.4 |
0.89 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104429 |
2948 |
SS-Kcnj1em1Kasu+/+ |
blood chloride level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood chloride amount |
male |
13 days
| 6 |
|
|
99.3 |
mmol/l |
0.8 |
1.96 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104430 |
2948 |
SS-Kcnj1em1Kasu+/- |
blood chloride level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood chloride amount |
male |
13 days
| 6 |
|
|
98.0 |
mmol/l |
0.6 |
1.47 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104431 |
2948 |
F344/NHsd |
blood eosinophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eosinophil quantity |
female |
56 days-98 days |
8 |
|
|
0.28 |
x 1000 cells/ul |
0.07 |
0.2 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68386 |
332 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
male |
90 days
| 15 |
|
|
0.7 |
mmol/l |
0.05 |
0.19 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68423 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
male |
90 days
| 10 |
|
|
0.85 |
mmol/l |
0.05 |
0.16 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68425 |
69 |
SHR/Mol |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood cholesterol amount |
male |
84 days-98 days |
12 |
|
|
77.22 |
mg/dl |
1.11 |
3.86 |
automated blood analysis |
opthalmic plexus |
|
0 |
|
mean of samples at 12, 13 and 14 weeks |
|
12935 |
323 |
SHR.SS-(D8Uia1-D8Rat90)/Mco |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
45.0 |
mg/dl |
1.1 |
3.11 |
automated blood analysis |
|
0 |
0 |
|
|
|
64810 |
246 |
SD |
blood aspartate aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
male |
71 days-85 days |
6 |
|
|
169.7 |
U/l |
11.38 |
27.88 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85071 |
1602 |
SD |
blood urea nitrogen level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
female |
71 days-85 days |
6 |
|
|
13.3 |
mg/dl |
0.96 |
2.34 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85042 |
1602 |
SD |
blood total cholesterol level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
male |
85 days-99 days |
6 |
|
|
73.99 |
mg/dl |
12.53 |
30.68 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85171 |
1602 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
70 days
| 19 |
|
|
20.5 |
mg/dl |
1.81 |
7.9 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85354 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
133 days
| 19 |
|
|
17.4 |
mg/dl |
0.85 |
3.7 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85364 |
1604 |
GK/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood glucose amount |
male |
60 days
| 6 |
|
|
258.66 |
mg/dl |
25.92 |
63.49 |
automated blood analysis |
|
0.0 |
0 |
|
automated plasma glucose analysis |
mM |
68774 |
1012 |
SS.ZUC-Leprfa-/-/Slc |
blood aspartate aminotransferase activity level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood aspartate transaminase amount |
male |
91 days
| 7 |
|
|
45.0 |
U/l |
3.53 |
9.34 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101859 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
blood alanine aminotransferase activity level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood alanine transaminase amount |
male |
91 days
| 12 |
|
|
46.67 |
U/l |
2.44 |
8.45 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101864 |
2641 |
SD-Fhem1+/- |
blood monocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
female |
0 days
| 3 |
|
|
0.1 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104904 |
2989 |
SD-Fhem1+/- |
blood monocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
monocyte quantity |
male |
0 days
| 3 |
|
|
3.3 |
% |
0.4 |
0.7 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104891 |
2989 |
SD-Fhem1+/- |
blood eosinophil count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
male |
0 days
| 3 |
|
|
1.0 |
% |
0.52 |
0.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104895 |
2989 |
SD-Fhem1+/- |
plasma direct bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
female |
0 days
| 3 |
|
|
0.4 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104948 |
2989 |
LE-Lrrk2em1Sage-/- |
plasma total bilirubin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood bilirubin amount |
male |
91 days
| 5 |
|
|
0.3 |
mg/dl |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104340 |
2947 |
SD-Fhem1+/+ |
blood uric acid level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood uric acid amount |
male |
0 days
| 3 |
|
|
4.04 |
mg/dl |
0.14 |
0.25 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104973 |
2989 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
78 days
| 19 |
|
|
0.41 |
mg/dl |
0.03 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85340 |
1604 |
SS/NEisSlc |
serum uric acid level |
controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood uric acid amount |
male |
91 days
| 12 |
|
|
0.03 |
umol/l |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
100682 |
2519 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
91 days
| 19 |
|
|
0.62 |
mg/dl |
0.01 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85342 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
91 days
| 19 |
|
|
25.2 |
mg/dl |
2.09 |
9.1 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85359 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
119 days
| 19 |
|
|
56.4 |
U/l |
2.13 |
9.3 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85418 |
1604 |
SHR.SS-(D8Uia1-D8Rat90)/Mco |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
3.4 |
mg/dl |
0.29 |
0.82 |
automated blood analysis |
|
0 |
0 |
|
|
|
65788 |
246 |
SHR.SS-(D13Rat1-D13Mgh6)/Mco |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
2.8 |
mg/dl |
0.14 |
0.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
65789 |
246 |
DA/BklArbNsi |
hematocrit |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
erythrocyte quantity |
female |
56 days-98 days |
7 |
|
|
38.4 |
% |
2.08 |
5.5 |
automated blood analysis |
|
0.0 |
0 |
|
Anilytics |
|
13163 |
332 |
SHR/NHsd |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
54.0 |
mg/dl |
2.4 |
6.79 |
automated blood analysis |
|
0 |
0 |
|
|
|
64811 |
246 |
SS/Jr |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
119.0 |
mg/dl |
5.3 |
14.99 |
automated blood analysis |
|
0 |
0 |
|
|
|
64814 |
246 |
SHR.SS-(D8Uia1-D8Rat90)/Mco |
serum albumin level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood albumin amount |
male |
84 days
| 8 |
|
|
3.6 |
g/dl |
0.3 |
0.85 |
automated blood analysis |
|
0 |
0 |
|
|
|
64816 |
246 |
SHR/NHsd |
serum albumin level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood albumin amount |
male |
84 days
| 8 |
|
|
4.2 |
g/dl |
0.17 |
0.48 |
automated blood analysis |
|
0 |
0 |
|
|
|
64817 |
246 |
SS.SHR-(D8Uia1-D8Rat90)/Mco |
serum albumin level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood albumin amount |
male |
84 days
| 8 |
|
|
3.2 |
g/dl |
0.04 |
0.11 |
automated blood analysis |
|
0 |
0 |
|
|
|
64819 |
246 |
F344/DuCrlCrlj |
plasma free fatty acids level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood free fatty acid amount |
male |
112 days
| 15 |
|
|
0.65 |
mmol/l |
0.03 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
|
"mEq/l" can not be converted to CMO:0000546's standard unit: "mmol/l" |
68969 |
1035 |
OLETF/Got |
plasma total cholesterol level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood cholesterol amount |
male |
112 days
| 25 |
|
|
54.83 |
mg/dl |
0.77 |
3.86 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68965 |
1035 |
F344/NHsd |
red blood cell count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
erythrocyte quantity |
female |
56 days-98 days |
8 |
|
|
0.01 |
x 10E6 cells/ul |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
0 |
|
Anilytics |
|
68376 |
332 |
BN/Crl |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
female |
90 days
| 17 |
|
|
0.88 |
mmol/l |
0.04 |
0.16 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68426 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
male |
90 days
| 10 |
|
|
1.25 |
mmol/l |
0.05 |
0.16 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68435 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
female |
90 days
| 6 |
|
|
1.22 |
mmol/l |
0.14 |
0.34 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68440 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
male |
90 days
| 15 |
|
|
15.83 |
mg/dl |
0.39 |
1.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68452 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
male |
90 days
| 10 |
|
|
11.97 |
mg/dl |
0.77 |
2.44 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68454 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
female |
90 days
| 6 |
|
|
10.42 |
mg/dl |
0.39 |
0.95 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68459 |
69 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
male |
90 days
| 13 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
19.31 |
mg/dl |
2.32 |
8.35 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68463 |
69 |
WKY/NCruk |
plasma creatinine level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175 days
| 19 |
|
|
0.65 |
mg/dl |
0.03 |
0.12 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67760 |
110 |
WKY/NCruk |
plasma urea nitrogen level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood urea nitrogen amount |
male |
35 days
| 20 |
|
|
5.12 |
mmol/l |
0.31 |
1.39 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67768 |
110 |
WKY/NCruk |
plasma creatinine level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
35 days
| 20 |
|
|
0.45 |
mg/dl |
0.02 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67770 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma creatinine level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
35 days
| 19 |
|
|
0.45 |
mg/dl |
0.02 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67771 |
110 |
BB.SHR-(Gnal-D18Mit9)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
female |
84 days
| 10 |
|
|
108.11 |
mg/dl |
1.34 |
4.25 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70104 |
324 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
105 days
| 19 |
|
|
14.7 |
U/l |
0.64 |
2.8 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85448 |
1604 |
SD |
blood sodium level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
male |
71 days-85 days |
6 |
|
|
144.7 |
mmol/l |
0.33 |
0.82 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85120 |
1602 |
SD |
blood sodium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
female |
71 days-85 days |
6 |
|
|
146.5 |
mmol/l |
0.43 |
1.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85125 |
1602 |
SD |
blood phosphate level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
male |
71 days-85 days |
6 |
|
|
6.0 |
mg/dl |
0.07 |
0.16 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85156 |
1602 |
SD |
blood phosphate level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
male |
71 days-85 days |
6 |
|
|
6.1 |
mg/dl |
0.22 |
0.55 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85157 |
1602 |
SD |
blood total cholesterol level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
male |
71 days-85 days |
6 |
|
|
86.8 |
mg/dl |
5.76 |
14.12 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85170 |
1602 |
SD |
blood triglyceride level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
male |
71 days-85 days |
6 |
|
|
52.3 |
mg/dl |
3.15 |
7.71 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85179 |
1602 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
78 days
| 19 |
|
|
13.7 |
U/l |
0.48 |
2.1 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85444 |
1604 |
DA/K |
blood glucose level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood glucose amount |
not specified |
196 days-224 days |
12 |
|
|
105.0 |
mg/dl |
2.31 |
8.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
96849 |
1123 |
FHH/EurMcwi |
plasma creatinine level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood creatinine amount |
male |
189 days
| 7 |
|
|
0.8 |
mg/dl |
0.1 |
0.26 |
automated blood analysis |
|
0.0 |
0 |
|
ACE Autoanalyzer Clinical Chemistry System |
|
96915 |
1738 |
Crl:CD(SD) |
plasma creatinine level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood creatinine amount |
male |
189 days
| 6 |
|
|
0.47 |
mg/dl |
0.03 |
0.07 |
automated blood analysis |
|
0.0 |
0 |
|
ACE Autoanalyzer Clinical Chemistry System |
|
96916 |
1738 |
SD |
blood glucose level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
female |
85 days-99 days |
6 |
|
|
90.83 |
mg/dl |
4.2 |
10.28 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84998 |
1602 |
SD |
blood urea nitrogen level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
male |
71 days-85 days |
6 |
|
|
15.5 |
mg/dl |
0.76 |
1.85 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85038 |
1602 |
SD |
blood urea nitrogen level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
female |
71 days-85 days |
6 |
|
|
15.5 |
mg/dl |
0.76 |
1.87 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85043 |
1602 |
SD |
blood urea nitrogen level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
female |
71 days-85 days |
6 |
|
|
38.2 |
mg/dl |
3.37 |
8.26 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85044 |
1602 |
SD |
blood urea nitrogen level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
female |
85 days-99 days |
6 |
|
|
21.0 |
mg/dl |
0.63 |
1.55 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85046 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
85 days-99 days |
6 |
|
|
0.66 |
null |
0.15 |
0.37 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85052 |
1602 |
SD |
blood albumin level to blood globulin level ratio |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
85 days-99 days |
6 |
|
|
0.93 |
null |
0.06 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85057 |
1602 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
male |
71 days-85 days |
6 |
|
|
178.5 |
U/l |
14.68 |
35.95 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85074 |
1602 |
SD |
blood alanine aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
male |
85 days-99 days |
6 |
|
|
46.73 |
U/l |
8.3 |
20.33 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85087 |
1602 |
SD |
blood alanine aminotransferase activity level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alanine transaminase amount |
male |
85 days-99 days |
6 |
|
|
39.74 |
U/l |
8.84 |
21.66 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85088 |
1602 |
SD |
blood bilirubin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
male |
71 days-85 days |
6 |
|
|
0.3 |
mg/dl |
0.04 |
0.09 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85107 |
1602 |
SD |
blood potassium level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
male |
71 days-85 days |
6 |
|
|
5.0 |
mmol/l |
0.15 |
0.36 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85133 |
1602 |
SD |
blood potassium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
female |
71 days-85 days |
6 |
|
|
2.27 |
mmol/l |
0.38 |
0.92 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85140 |
1602 |
SD |
blood phosphate level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
female |
71 days-85 days |
6 |
|
|
5.88 |
mg/dl |
0.16 |
0.4 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85162 |
1602 |
SD |
blood calcium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
male |
71 days-85 days |
6 |
|
|
10.0 |
mg/dl |
0.1 |
0.25 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85143 |
1602 |
SD |
blood calcium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
male |
71 days-85 days |
6 |
|
|
9.9 |
mg/dl |
0.04 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85146 |
1602 |
SD |
blood calcium level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
male |
85 days-99 days |
6 |
|
|
7.03 |
mg/dl |
1.67 |
4.1 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85148 |
1602 |
SD |
blood phosphate level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
male |
71 days-85 days |
6 |
|
|
5.9 |
mg/dl |
0.18 |
0.43 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85158 |
1602 |
SD |
blood total cholesterol level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
female |
71 days-85 days |
6 |
|
|
102.3 |
mg/dl |
3.01 |
7.37 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85175 |
1602 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
133 days
| 19 |
|
|
0.55 |
mg/dl |
0.03 |
0.12 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85348 |
1604 |
SD |
blood globulin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
female |
85 days-99 days |
6 |
|
|
3.0 |
g/dl |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85033 |
1602 |
SD |
blood globulin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
female |
85 days-99 days |
6 |
|
|
3.08 |
g/dl |
0.04 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85034 |
1602 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
91 days
| 19 |
|
|
124.0 |
mg/dl |
2.29 |
10.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85327 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
119 days
| 19 |
|
|
129.0 |
mg/dl |
2.29 |
10.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85330 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
147 days
| 19 |
|
|
126.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85335 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
168 days
| 19 |
|
|
131.0 |
mg/dl |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85336 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
105 days
| 19 |
|
|
0.49 |
mg/dl |
0.02 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85344 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
147 days
| 19 |
|
|
0.47 |
mg/dl |
0.05 |
0.21 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85350 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
78 days
| 19 |
|
|
33.9 |
U/l |
0.83 |
3.6 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85428 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
70 days
| 19 |
|
|
14.3 |
U/l |
0.55 |
2.4 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85442 |
1604 |
SD |
blood albumin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
85 days-99 days |
6 |
|
|
3.62 |
g/dl |
0.04 |
0.09 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85010 |
1602 |
SD |
blood albumin level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71 days-85 days |
6 |
|
|
3.5 |
g/dl |
0.08 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85002 |
1602 |
SD |
blood albumin level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
71 days-85 days |
6 |
|
|
3.5 |
g/dl |
0.14 |
0.35 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85006 |
1602 |
SS.ZUC-Leprfa+/+/Slc |
serum aspartate aminotransferase activity level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood aspartate transaminase amount |
male |
126 days
| 6 |
|
|
57.0 |
U/l |
1.52 |
3.72 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101927 |
2642 |
SS.ZUC-Leprfa-/-/Slc |
serum alanine aminotransferase activity level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood alanine transaminase amount |
male |
126 days
| 7 |
|
|
39.25 |
U/l |
2.63 |
6.96 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101930 |
2642 |
SD-Fhem1+/- |
blood hemoglobin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
0 days
| 3 |
|
|
1450.0 |
g/dl |
40.41 |
70.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104856 |
2989 |
SD-Fhem1+/- |
hematocrit |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte quantity |
female |
0 days
| 3 |
|
|
41.7 |
% |
0.92 |
1.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104860 |
2989 |
SD-Fhem1+/+ |
platelet count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet quantity |
male |
0 days
| 3 |
|
|
1106.3 |
x 1000 /ul |
86.83 |
150.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104861 |
2989 |
SD-Fhem1+/- |
platelet count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet quantity |
male |
0 days
| 3 |
|
|
1004.0 |
x 1000 /ul |
80.6 |
139.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104863 |
2989 |
SD-Fhem1+/+ |
mean platelet volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
0 days
| 3 |
|
|
8.5 |
fl |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104866 |
2989 |
SD-Fhem1+/- |
mean platelet volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
0 days
| 3 |
|
|
8.7 |
fl |
0.23 |
0.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104868 |
2989 |
SD-Fhem1+/+ |
mean corpuscular hemoglobin |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
male |
0 days
| 3 |
|
|
16.9 |
pg |
0.17 |
0.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104877 |
2989 |
LE-Lrrk2em1Sage-/- |
blood segmented neutrophil count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
neutrophil quantity |
male |
91 days
| 5 |
|
|
13.8 |
% |
0.98 |
2.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104368 |
2947 |
Crl:LE |
blood monocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
monocyte quantity |
male |
91 days
| 5 |
|
|
1.6 |
% |
0.58 |
1.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104371 |
2947 |
LE-Lrrk2em1Sage-/- |
blood eosinophil count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
eosinophil quantity |
male |
91 days
| 5 |
|
|
1.0 |
% |
|
|
automated blood analysis |
|
0.0 |
0 |
|
|
|
104374 |
2947 |
LE-Lrrk2em1Sage-/- |
blood segmented neutrophil count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
neutrophil quantity |
male |
91 days
| 5 |
|
|
1032.0 |
cells/ul |
74.68 |
167.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104378 |
2947 |
LE-Lrrk2em1Sage-/- |
blood monocyte count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
monocyte quantity |
male |
91 days
| 5 |
|
|
0.11 |
x 1000 cells/ul |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104382 |
2947 |
SD-Fhem1+/+ |
blood protein measurement |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood total protein amount |
male |
0 days
| 3 |
|
|
644.0 |
g/dl |
9.24 |
16.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104953 |
2989 |
SD-Fhem1+/+ |
blood protein measurement |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood total protein amount |
female |
0 days
| 3 |
|
|
651.0 |
g/dl |
57.16 |
99.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104954 |
2989 |
SD-Fhem1+/- |
blood uric acid level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood uric acid amount |
male |
0 days
| 3 |
|
|
3.07 |
mg/dl |
0.14 |
0.24 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104975 |
2989 |
Crl:LE |
blood lymphocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lymphocyte quantity |
male |
91 days
| 5 |
|
|
84.8 |
% |
1.61 |
3.6 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104369 |
2947 |
SD-Fhem1+/+ |
blood lymphocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
female |
0 days
| 3 |
|
|
57.1 |
% |
4.56 |
7.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104886 |
2989 |
SD-Fhem1+/- |
blood lymphocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
male |
0 days
| 3 |
|
|
50.7 |
% |
4.04 |
7.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104887 |
2989 |
SD-Fhem1+/+ |
blood monocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
monocyte quantity |
female |
0 days
| 3 |
|
|
4.5 |
% |
0.52 |
0.9 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104890 |
2989 |
SD-Fhem1+/+ |
platelet-large cell ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
0 days
| 3 |
|
|
14.8 |
% |
0.87 |
1.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104922 |
2989 |
SD-Fhem1+/+ |
plasma direct bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
male |
0 days
| 3 |
|
|
0.2 |
umol/l |
0.06 |
0.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104945 |
2989 |
SD-Fhem1+/+ |
plasma indirect bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
female |
0 days
| 3 |
|
|
0.1 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104950 |
2989 |
SD-Fhem1+/- |
plasma indirect bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
female |
0 days
| 3 |
|
|
-0.2 |
umol/l |
0.17 |
0.3 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104952 |
2989 |
Crl:LE |
blood alkaline phosphatase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood alkaline phosphatase amount |
male |
91 days
| 5 |
|
|
196.0 |
U/l |
13.01 |
29.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104321 |
2947 |
SS-Kcnj1em1Kasu+/+ |
blood bicarbonate level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood bicarbonate amount |
male |
13 days
| 6 |
|
|
29.2 |
mmol/l |
0.9 |
2.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104433 |
2948 |
LE-Lrrk2em1Sage-/- |
blood monocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
monocyte quantity |
male |
91 days
| 5 |
|
|
1.4 |
% |
0.22 |
0.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104372 |
2947 |
LE-Lrrk2em1Sage-/- |
plasma total protein level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood total protein amount |
male |
91 days
| 5 |
|
|
65.0 |
mg/ml |
0.89 |
2.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104330 |
2947 |
SD-Fhem1+/+ |
blood globulin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood globulin amount |
female |
0 days
| 3 |
|
|
296.0 |
g/dl |
34.64 |
60.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104962 |
2989 |
SD-Fhem1+/- |
blood globulin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood globulin amount |
female |
0 days
| 3 |
|
|
305.0 |
g/dl |
4.62 |
8.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104964 |
2989 |
SD-Fhem1+/+ |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
female |
0 days
| 3 |
|
|
115.2 |
mg/dl |
14.55 |
25.2 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104966 |
2989 |
SD-Fhem1+/- |
blood urea nitrogen level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood urea nitrogen amount |
female |
0 days
| 3 |
|
|
920.0 |
mg/dl |
57.74 |
100.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104972 |
2989 |
SD-Fhem1+/+ |
blood albumin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood albumin amount |
female |
0 days
| 3 |
|
|
355.0 |
g/dl |
23.67 |
41.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104958 |
2989 |
SD-Fhem1+/- |
blood albumin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood albumin amount |
female |
0 days
| 3 |
|
|
373.0 |
g/dl |
12.7 |
22.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104960 |
2989 |
BB.SHR-(D4Mit6-Spr)/K |
serum triglyceride level |
control condition |
Kovacs P and Kloting I, Arch Biochem Biophys 1998 Jun 1;354(1):139-43. |
blood triglyceride amount |
male |
84 days
| 0 |
|
|
176.99 |
mg/dl |
|
35.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
106820 |
1034 |
WOKW |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood triglyceride amount |
female |
196 days-224 days |
12 |
|
serial mean |
292.04 |
mg/dl |
|
|
automated blood analysis |
ophthalmic venous plexus |
0.0 |
0 |
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
12423 |
251 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
male |
84 days
| 22 |
|
|
141.59 |
mg/dl |
13.4 |
62.83 |
automated blood analysis |
opthalmic venous plexus |
|
0 |
|
|
|
12986 |
324 |
SS.SHR-(D13Rat63-D13Mit1)/Mco |
serum albumin level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood albumin amount |
male |
84 days
| 8 |
|
|
3.2 |
g/dl |
0.04 |
0.11 |
automated blood analysis |
|
0 |
0 |
|
|
|
64818 |
246 |
SD |
blood creatinine level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
female |
71 days-85 days |
6 |
|
|
1.1 |
mg/dl |
0.15 |
0.36 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85068 |
1602 |
SD |
blood aspartate aminotransferase activity level |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
male |
71 days-85 days |
6 |
|
|
140.8 |
U/l |
8.19 |
20.06 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85073 |
1602 |
BN/Crl |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
female |
90 days
| 15 |
|
|
1.44 |
mmol/l |
0.05 |
0.19 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68436 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
male |
90 days
| 10 |
|
|
62.93 |
mg/dl |
1.54 |
4.88 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68414 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
female |
90 days
| 14 |
|
|
64.48 |
mg/dl |
1.93 |
7.22 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68417 |
69 |
BB.SHR-(Gnal-D18Mit9)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
male |
84 days
| 15 |
|
|
111.97 |
mg/dl |
3.69 |
14.29 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
0 |
|
|
|
70103 |
324 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
78 days
| 19 |
|
|
35.0 |
U/l |
1.49 |
6.5 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85429 |
1604 |
F344/DuCrlCrlj |
plasma total cholesterol level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood cholesterol amount |
male |
112 days
| 15 |
|
|
38.61 |
mg/dl |
1.54 |
5.98 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68967 |
1035 |
SD |
blood triglyceride level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood triglyceride amount |
female |
85 days-99 days |
6 |
|
|
32.67 |
mg/dl |
2.35 |
5.75 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85189 |
1602 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
70 days
| 19 |
|
|
0.54 |
mg/dl |
0.03 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85338 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
105 days
| 19 |
|
|
15.0 |
mg/dl |
0.48 |
2.1 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85360 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
147 days
| 19 |
|
|
19.4 |
mg/dl |
0.78 |
3.4 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85367 |
1604 |
SD-Fhem1+/+ |
blood hemoglobin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
0 days
| 3 |
|
|
1320.0 |
g/dl |
75.63 |
131.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104854 |
2989 |
SD-Fhem1+/- |
mean platelet volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
male |
0 days
| 3 |
|
|
8.1 |
fl |
0.29 |
0.5 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104867 |
2989 |
SD-Fhem1+/- |
mean corpuscular volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
0 days
| 3 |
|
|
47.2 |
fl |
0.81 |
1.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104875 |
2989 |
SD-Fhem1+/+ |
mean corpuscular hemoglobin |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
0 days
| 3 |
|
|
18.3 |
pg |
0.46 |
0.8 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104878 |
2989 |
SD-Fhem1+/- |
mean corpuscular hemoglobin |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
0 days
| 3 |
|
|
17.7 |
pg |
0.23 |
0.4 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104880 |
2989 |
SD-Fhem1+/- |
red blood cell distribution width- standard deviation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
0 days
| 3 |
|
|
28.0 |
% |
0.98 |
1.7 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104911 |
2989 |
SD-Fhem1+/- |
platelet distribution width |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
0 days
| 3 |
|
|
9.8 |
fl |
0.4 |
0.7 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104920 |
2989 |
SD-Fhem1+/+ |
blood aspartate aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood aspartate transaminase amount |
male |
0 days
| 3 |
|
|
130.3 |
U/l |
5.83 |
10.1 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104929 |
2989 |
SD-Fhem1+/+ |
blood alkaline phosphatase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood alkaline phosphatase amount |
male |
0 days
| 3 |
|
|
84.7 |
U/l |
17.9 |
31.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104937 |
2989 |
SD-Fhem1+/- |
blood globulin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood globulin amount |
male |
0 days
| 3 |
|
|
301.0 |
g/dl |
6.35 |
11.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104963 |
2989 |
SD |
blood glucose level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood glucose amount |
male |
71 days-85 days |
6 |
|
|
86.8 |
mg/dl |
4.51 |
11.05 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
84990 |
1602 |
SS.ZUC-Leprfa+/+/Slc |
blood alanine aminotransferase activity level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood alanine transaminase amount |
male |
91 days
| 10 |
|
|
25.5 |
U/l |
1.15 |
3.64 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
101862 |
2641 |
SD |
blood potassium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
female |
71 days-85 days |
6 |
|
|
4.57 |
mmol/l |
0.08 |
0.19 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85137 |
1602 |
SD |
blood phosphate level |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
female |
71 days-85 days |
6 |
|
|
6.53 |
mg/dl |
0.39 |
0.96 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85164 |
1602 |
SD-Fhem1+/- |
blood albumin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood albumin amount |
male |
0 days
| 3 |
|
|
339.0 |
g/dl |
5.2 |
9.0 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
104959 |
2989 |
SD |
blood calcium level |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
male |
71 days-85 days |
6 |
|
|
10.0 |
mg/dl |
0.09 |
0.23 |
automated blood analysis |
|
0.0 |
0 |
|
Siemens biochemical analyzer |
|
85144 |
1602 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
133 days
| 19 |
|
|
124.0 |
mg/dl |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85333 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
105 days
| 19 |
|
|
0.81 |
mg/dl |
0.06 |
0.27 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85345 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
70 days
| 19 |
|
|
15.9 |
U/l |
1.17 |
5.1 |
automated blood analysis |
|
0.0 |
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85443 |
1604 |
SHR/Mol |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood cholesterol amount |
female |
84 days-98 days |
12 |
|
|
88.8 |
mg/dl |
2.23 |
7.72 |
automated blood analysis |
opthalmic plexus |
|
0 |
|
mean of samples at 12, 13 and 14 weeks |
|
12936 |
323 |
SS.SHR-(D13Rat63-D13Mit1)/Mco |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
28 days-84 days |
8 |
|
|
55.0 |
mg/dl |
3.4 |
9.62 |
automated blood analysis |
|
|
0 |
|
|
|
12401 |
246 |
DA/BklArbNsi |
mean corpuscular volume |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
erythrocyte size trait |
female |
56 days-98 days |
7 |
|
|
52.0 |
fl |
0.79 |
2.1 |
automated blood analysis |
|
0.0 |
0 |
|
Anilytics |
|
13169 |
332 |
SS/Jr |
serum albumin level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood albumin amount |
male |
84 days
| 8 |
|
|
2.9 |
g/dl |
0.06 |
0.17 |
automated blood analysis |
|
0 |
0 |
|
|
|
64820 |
246 |
DA/BklArbNsi |
blood neutrophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
neutrophil quantity |
female |
56 days-98 days |
7 |
|
|
2.32 |
x 1000 cells/ul |
0.49 |
1.3 |
automated blood analysis |
heart or retroorbital sinus |
0.0 |
0 |
|
Anilytics |
|
68379 |
332 |
DA/BklArbNsi |
blood monocyte count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
monocyte quantity |
female |
56 days-98 days |
7 |
|
|
0.46 |
x 1000 cells/ul |
0.19 |
0.5 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68383 |
332 |
DA/BklArbNsi |
blood basophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
basophil quantity |
female |
56 days-98 days |
7 |
|
|
0.48 |
x 1000 cells/ul |
0.11 |
0.3 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68387 |
332 |
F344/NHsd |
blood basophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
basophil quantity |
female |
56 days-98 days |
8 |
|
|
0.64 |
x 1000 cells/ul |
0.21 |
0.6 |
automated blood analysis |
blood |
0.0 |
0 |
|
Anilytics |
|
68388 |
332 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
male |
90 days
| 15 |
|
|
57.14 |
mg/dl |
1.93 |
7.48 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68413 |
69 |
BN/Crl |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood cholesterol amount |
female |
90 days
| 18 |
|
|
66.41 |
mg/dl |
1.93 |
8.19 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68416 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
male |
90 days
| 16 |
|
|
0.75 |
mmol/l |
0.04 |
0.16 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68422 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
male |
90 days
| 10 |
|
|
0.72 |
mmol/l |
0.04 |
0.13 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68424 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
female |
90 days
| 14 |
|
|
1.0 |
mmol/l |
0.04 |
0.15 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68427 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood triglyceride amount |
female |
90 days
| 6 |
|
|
0.71 |
mmol/l |
0.1 |
0.24 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68430 |
69 |
BN.GK-(D2Wox30-D2Wox68)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood phospholipid amount |
female |
90 days
| 8 |
|
|
1.26 |
mmol/l |
0.08 |
0.23 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68438 |
69 |
BN.GK-(D2Rat40-D2Wox35)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
male |
90 days
| 10 |
|
|
27.8 |
mg/dl |
1.16 |
3.66 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68444 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood HDL cholesterol amount |
female |
90 days
| 14 |
|
|
31.66 |
mg/dl |
0.77 |
2.89 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68447 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood LDL cholesterol amount |
female |
90 days
| 14 |
|
|
8.11 |
mg/dl |
0.77 |
2.89 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68457 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
male |
90 days
| 15 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
15.83 |
mg/dl |
2.7 |
10.47 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68462 |
69 |
BN.GK-(D2Rat40-D2Got149)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
male |
90 days
| 10 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
21.62 |
mg/dl |
1.16 |
3.66 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68465 |
69 |
BN.GK-(D2Wox49-D2Rat70)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
blood VLDL cholesterol amount |
female |
90 days
| 14 |
TC-(HDL-C + LDL-C)=VLDL-C |
|
24.32 |
mg/dl |
1.54 |
5.78 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
68467 |
69 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma urea nitrogen level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood urea nitrogen amount |
male |
175 days
| 20 |
|
|
5.16 |
mmol/l |
0.12 |
0.55 |
automated blood analysis |
|
0.0 |
0 |
|
|
|
67753 |
110 |
WKY/NCruk |
plasma urea nitrogen level |
left nephrectom |